Dr. Franke is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
214 14th Ave SW
PO Box 100278
Sidney, MT 59270Phone+1 406-488-3976
Summary
- Former Assistant Professor and Associate Research Leader for the Thoracic Cancers Disease Site Group at University of Florida/UF Health Cancer Center.
Currently practicing general hematology and medical oncology in Sidney, Montana, providing much needed clinical care to the rural MonDak patient population.
Education & Training
- University of South Florida MorsaniFellowship, Hematology and Medical Oncology, 2018 - 2021
- University of FloridaResidency, Internal Medicine, 2015 - 2018
- University of FloridaInternship, Internal Medicine, 2015 - 2016
- Saba University School of MedicineClass of 2015
- Florida State UniversityBS, Psychology, Physics, 2006 - 2010
Certifications & Licensure
- FL State Medical License 2019 - 2027
- MT State Medical License 2023 - 2025
- ME State Medical License 2023 - 2024
- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Hematology
- American Board of Internal Medicine Medical Oncology
Awards, Honors, & Recognition
- Spotlight Oncologist University of Florida Cancer Awareness and Prevention Network, 2021
- Exemplary mentor of the year: senior resident teaching award UF College of Medicine, 2018
- Dean of Clinical Medicine Award 2015
- Join now to see all
Clinical Trials
- Autologous LN-145 in Patients With Metastatic Non-Small-Cell Lung Cancer Start of enrollment: 2021 May 07
- A Study to Assess BMS-986207 in Combination With Nivolumab and Ipilimumab as First-line Treatment for Participants With Stage IV Non-Small Cell Lung Cancer Start of enrollment: 2022 Oct 03
Publications & Presentations
PubMed
- Re-ORIENT-ing antitumor immunity in EGFR-mutant non-small cell lung cancer: are antiangiogenics the key?Aaron J Franke, Erin L Schenk
Chinese Clinical Oncology. 2023-06-01 - 2 citationsImpact of Institutional Universal Microsatellite-Instability (MSI) Reflex Testing on Molecular Profiling Differences Between Younger and Older Patients with Colorectal...Ellery Altshuler, Aaron J Franke, William Paul Skelton 4th, Michael Feely, Yu Wang
Clinical Colorectal Cancer. 2023-03-01 - 2 citationsExtremely delayed-onset post-transplant lymphoproliferative disorder in a renal transplant patient.Ethan Holland, Ellery Altshuler, Aaron J Franke
BMJ Case Reports. 2022-08-17
Abstracts/Posters
- Lorlatinib rescue therapy for life threatening CNS disease in crizotinib-resistant ROS1-positive NSCLCFranke AJ, Nair VS, Shafique M, Mokhtari S., Journal of Thoracic Oncology/2019 IASLC WCLC, Barcelona, Spain, 10/1/2019
- Predictive clinical and molecular features of long-term survivors receiving immune checkpoint inhibitors for stage 4 NSCLC.Franke AJ, Antonia SJ, Haura EB, Chiappori A, Tanvetyanon T, et al., Journal of Thoracic Oncology/IASLC 2019 WCLC, Barcelona, Spain, 10/1/2019
- Results of a phase II trial of the PARP inhibitor, niraparib, in BAP1 and other DNA damage response pathway deficient neoplasms.George TJ, Lee JH, Hosein PJ....... Franke AJ, et al., JCO/2022 ASCO Annual Meeting, Chicago, IL, 6/1/2022
- Join now to see all
Authored Content
- EGFR-Targeted Therapy in Advanced NSCLC Patients With Uncommon EGFR MutationsMay 2023
- Traveling Through the Lung Cancer Treatment Paradigm: Biomarker Guidance in NSCLCFebruary 2023
- Traveling Through the Lung Cancer Treatment Paradigm: Moving Cellular Therapies Across SettingsFebruary 2023
- Current Challenges Facing the Shifting Paradigm of Early-Stage NSCLC ManagementNovember 2022
- Colorectal Cancer Makeup May Differ by Age Group6/25/2018
- Join now to see all
Press Mentions
- FDA Approves Immunotherapy Combination for Metastatic Colorectal CancerJuly 11th, 2018
- UF study finds younger patients with colorectal cancer less likely to have targetable genetic mutationsNovember 8th, 2022
Committees
- Appointed Faculty Committee Member, ASCO TAPUR Molecular Tumor Board 2022 - Present
- Appointed Committee Member, NCI-NCTN NRG Oncology Lung Cancer Committee 2021 - Present
- Associate Research Leader, UFHCC Thoracic Cancers Disease Site Group 2021 - 2023
- Voting Member, UFHCC Scientific Review and Monitoring Committee 2021 - 2023
- Member, UFHCC Cancer Therapeutics Host Response Research Program 2021 - 2023
- Director, Multidisciplinary Leadership Journal Club 2020 - 2021
- Board Member, Gator Council Research & ABIM Committee 2016 - 2018
Professional Memberships
- Member
- Member
- Member
- Member
- International Association for the Study of Lung Cancer (IASLC)Member
- Florida Society of Clinical Oncology (FLASCO)Member
- Member
Other Languages
- Spanish
External Links
- Google Scholar Citationshttps://scholar.google.com/citations?user=6wzMH3wAAAAJ&hl=en
- ResearchGatehttps://www.researchgate.net/profile/Aaron_Franke3
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: